|
[1]
|
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J.R., Young, J.A. and Boeckh, M.J. (2009) Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective. Preface. Bone Marrow Transplant, 44, 453-455. http://dx.doi.orgdoi: /10.1038/bmt.2009.254
|
|
[2]
|
Kruger, W., Russmann, B., Kroger, N., Salomon, C., Ekopf, N., Elsner, H.A., Kaulfers, P.M., Mack, D., Fuchs, N., Durken, M., Kabisch, H., Erttmann, R. and Zander, A.R. (1999) Early Infections in Patients Undergoing Bone Marrow or Blood Stem Cell Transplantation—A 7 Year Single Centre Investigation of 409 Cases. Bone Marrow Transplant, 23, 589-597. http://dx.doi.org/10.1038/sj.bmt.1701614
|
|
[3]
|
Viscoli, C., Varnier, O. and Machetti, M. (2005) Infections in Patients with Febrile Neutropenia: Epidemiology, Microbiology, and Risk Stratification. Clinical Infectious Diseases, 40, S240-S245. http://dx.doi.org/10.1086/427329
|
|
[4]
|
Collin, B.A., Leather, H.L., Wingard, J.R. and Ramphal, R. (2001) Evolution, Incidence, and Susceptibility of Bacterial Bloodstream Isolates from 519 Bone Marrow Transplant Patients. Clinical Infectious Diseases, 33, 947-953.
http://dx.doi.org/10.1086/322604
|
|
[5]
|
Mendes, E.T., Dulley, F., Basso, M., Batista, M.V., Coracin, F., Guimaraes, T., Shikanai-Yasuda, M.A., Levin, A.S. and Costa, S.F. (2012) Healthcare-Associated Infection in Hematopoietic Stem Cell Transplantation Patients: Risk Factors and Impact on Outcome. International Journal of Infectious Diseases, 16, E424-E428.
http://dx.doi.org/10.1016/j.ijid.2012.01.015
|
|
[6]
|
Oliveira, A.L., de Souza, M., Carvalho-Dias, V.M., Ruiz, M.A., Silla, L., Tanaka, P.Y., Simoes, B.P., Trabasso, P., Seber, A., Lotfi, C.J., Zanichelli, M.A., Araujo, V.R., Godoy, C., Maiolino, A., Urakawa, P., Cunha, C.A., de Souza, C.A., Pasquini, R. and Nucci, M. (2007) Epidemiology of Bacteremia and Factors Associated with Multi-Drug-Resistant Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients. Bone Marrow Transplant, 39, 775-781.
http://dx.doi.org/10.1038/sj.bmt.1705677
|
|
[7]
|
Viscoli, C. (2007) Antibacterial Prophylaxis in Neutropenic Patients. International Journal of Antimicrobial Agents, 30, S60-S65. http://dx.doi.org/10.1016/j.ijantimicag.2007.06.016
|
|
[8]
|
Flowers, C.R., Seidenfeld, J., Bow, E.J., Karten, C., Gleason, C., Hawley, D.K., Kuderer, N.M., Langston, A.A., Marr, K.A., Rolston, K.V. and Ramsey, S.D. (2013) Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology, 31, 794-810. http://dx.doi.org/10.1200/JCO.2012.45.8661
|
|
[9]
|
Freifeld, A.G., Bow, E.J., Sepkowitz, K.A., Boeckh, M.J., Ito, J.I., Mullen, C.A., Raad, I.I., Rolston, K.V., Young, J.A. and Wingard, J.R. (2011) Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 52, E56-E93.
http://dx.doi.org/10.1093/cid/cir073
|
|
[10]
|
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J.R., Young, J.A. and Boeckh, M.J. (2009) Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective. Biology of Blood and Marrow Transplantation, 15, 1143-1238.
http://dx.doi.org/10.1016/j.bbmt.2009.06.019
|
|
[11]
|
van de Wetering, M.D., de Witte, M.A., Kremer, L.C., Offringa, M., Scholten, R.J. and Caron, H.N. (2005) Efficacy of Oral Prophylactic Antibiotics in Neutropenic Afebrile Oncology Patients: A Systematic Review of Randomised Controlled Trials. European Journal of Cancer, 41, 1372-1382.
http://dx.doi.org/10.1016/j.ejca.2005.03.006
|
|
[12]
|
Gafter-Gvili, A., Fraser, A., Paul, M. and Leibovici, L. (2005) Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients. Annals of Internal Medicine, 142, 979-995.
http://dx.doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00008
|
|
[13]
|
Gafter-Gvili, A., Fraser, A., Paul, M., Vidal, L., Lawrie, T.A., van de Wetering, M.D., Kremer, L.C. and Leibovici, L. (2005) Antibiotic Prophylaxis for Bacterial Infections in Afebrile Neutropenic Patients Following Chemotherapy. The Cochrane Database of Systematic Reviews, Article ID: CD004386.
http://dx.doi.org/10.1002/14651858.CD004386.pub3
|
|
[14]
|
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M.S., Martinelli, G., Allione, B., D’Antonio, D., Buelli, M., Nosari, A.M., Cilloni, D., Zuffa, E., Cantaffa, R., Specchia, G., Amadori, S., Fabbiano, F., Deliliers, G.L., Lauria, F., Foa, R. and Del Favero, A. (2005) Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia. The New England Journal of Medicine, 353, 977-987. http://dx.doi.org/10.1056/NEJMoa044097
|
|
[15]
|
Lew, M.A., Kehoe, K., Ritz, J., Antman, K.H., Nadler, L., Takvorian, T., Mayer, R., Kalish, L. and Finberg, R. (1991) Prophylaxis of Bacterial Infections with Ciprofloxacin in Patients Undergoing Bone Marrow Transplantation. Transplantation, 51, 630-636. http://dx.doi.org/10.1097/00007890-199103000-00017
|
|
[16]
|
Perez-Simon, J.A., Garcia-Escobar, I., Martinez, J., Vazquez, L., Caballero, D., Canizo, C., Mateos, M.V. and San Miguel, J.F. (2004) Antibiotic Prophylaxis with Meropenem after Allogeneic Stem Cell Transplantation. Bone Marrow Transplantation, 33, 183-187.
http://dx.doi.org/10.1038/sj.bmt.1704335
|
|
[17]
|
Eleutherakis-Papaiakovou, E., Kostis, E., Migkou, M., Christoulas, D., Terpos, E., Gavriatopoulou, M., Roussou, M., Bournakis, E., Kastritis, E., Efstathiou, E., Dimopoulos, M.A. and Papadimitriou, C.A. (2010) Prophylactic Antibiotics for the Prevention of Neutropenic Fever in Patients Undergoing Autologous Stem-Cell Transplantation: Results of a Single Institution, Randomized Phase 2 Trial. American Journal of Hematology, 85, 863-867.
http://dx.doi.org/10.1002/ajh.21855
|
|
[18]
|
Fernandez-Aviles, F., Carreras, E., Urbano-Ispizua, A., Rovira, M., Martinez, C., Gaya, A., Granell, M., Ramiro, L., Gallego, C., Hernando, A., Segura, S., Garcia, L., Gonzalez, M., Valverde, M. and Montserrat, E. (2006) Case-Control Comparison of At-Home to Total Hospital Care for Autologous Stem-Cell Transplantation for Hematologic Malignancies. Journal of Clinical Oncology, 24, 4855-4861. http://dx.doi.org/10.1200/JCO.2006.06.4238
|
|
[19]
|
Solano, C., Gutierrez, A., Martinez, F., Gimeno, C., Gomez, C., Munoz, I., Faus, F., Goterris, R., Farga, A. and Navarro, D. (2005) Prophylaxis of Early Bacterial Infections after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT): A Matched-Pair Study Comparing Oral Fluoroquinolones and Intravenous Piperacillin-Tazobactam. Bone Marrow Transplantation, 36, 59-65.
http://dx.doi.org/10.1038/sj.bmt.1705005
|
|
[20]
|
Guthrie, K.A., Yong, M., Frieze, D., Corey, L. and Fredricks, D.N. (2010) The Impact of a Change in Antibacterial Prophylaxis from Ceftazidime to Levofloxacin in Allogeneic Hematopoietic Cell Transplantation. Bone Marrow Transplantation, 45, 675-681.
http://dx.doi.org/10.1038/bmt.2009.216
|
|
[21]
|
Sohn, B.S., Yoon, D.H., Kim, S., Lee, K., Kang, E.H., Park, J.S., Lee, D.H., Kim, S.H., Huh, J. and Suh, C. (2012) The Role of Prophylactic Antimicrobials during Autologous Stem Cell Transplantation: A Single-Center Experience. European Journal of Clinical Microbiology & Infectious Diseases, 31, 1653-1661.
http://dx.doi.org/10.1007/s10096-011-1489-2
|
|
[22]
|
Vehreschild, J.J., Moritz, G., Vehreschild, M.J., Arenz, D., Mahne, M., Bredenfeld, H., Chemnitz, J., Klein, F., Cremer, B., Boll, B., Kaul, I., Wassmer, G., Hallek, M., Scheid, C. and Cornely, O.A. (2012) Efficacy and Safety of Moxifloxacin as Antibacterial Prophylaxis for Patients Receiving Autologous Haematopoietic Stem Cell Transplantation: A Randomised Trial. International Journal of Antimicrobial Agents, 39, 130-134.
http://dx.doi.org/10.1016/j.ijantimicag.2011.10.009
|
|
[23]
|
Urabe, A. (2004) Clinical Features of the Neutropenic Host: Definitions and Initial Evaluation. Clinical Infectious Diseases, 39, S53-S55. http://dx.doi.org/10.1086/383055
|
|
[24]
|
Kiffer, C.R., Mendes, C., Oplustil, C.P. and Sampaio, J.L. (2007) Antibiotic Resistance and Trend of Urinary Pathogens in General Outpatients from a Major Urban City. International Braz J Urol: Official Journal of Brazilian Society of Urology (Int Braz J Urol), 33, 42-48.
http://dx.doi.org/10.1590/S1677-55382007000100007
|
|
[25]
|
Leibovici, L., Paul, M., Cullen, M., Bucaneve, G., Gafter-Gvili, A., Fraser, A. and Kern, W.V. (2006) Antibiotic Prophylaxis in Neutropenic Patients: New Evidence, Practical Decisions. Cancer, 107, 1743-1751.
http://dx.doi.org/10.1002/cncr.22205
|
|
[26]
|
Facchini, L., Martino, R., Ferrari, A., Pinana, J.L., Valcarcel, D., Barba, P., Granell, M., Delgado, J., Briones, J., Sureda, A., Brunet, S. and Sierra, J. (2012) Degree of Mucositis and Duration of Neutropenia Are the Major Risk Factors for Early Post-Transplant Febrile Neutropenia and Severe Bacterial Infections after Reduced-Intensity Conditioning. European Journal of Haematology, 88, 46-51. http://dx.doi.org/10.1111/j.1600-0609.2011.01724.x
|
|
[27]
|
(1991) Prevention of Bacterial Infection in Neutropenic Patients with Hematologic Malignancies. A Randomized, Multicenter Trial Comparing Norfloxacin with Ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. Annals of Internal Medicine, 115, 7-12.
http://dx.doi.org/10.7326/0003-4819-115-1-7
|